Sale of FRAmelco to Bluestar Adisseo

Sector(s)
Food & Agro / Healthcare
Deal type
Sell your business
Date
December 2020
Countries involved
Benelux, France, China

Client

FRAmelco is specialized in the development, manufacturing and marketing of feed and drinking water additives worldwide. It provides the industry with additive solutions that allow both agriculture and aquaculture to increase productivity and profitability in a sustainable manner.

Deal

Capitalmind has advised the shareholders of FRAmelco on the sale to Bluestar Adisseo (Chinese listed)

Parties

Lead team

  • Bart Jonkman

    Bart Jonkman

    Managing Partner Benelux
  • Jan Willem Jonkman

    Jan Willem Jonkman

    Managing Partner Benelux
  • Marleen Vermeer

    Marleen Vermeer

    Partner Benelux

About the deal

FRAmelco Group, a family-owned multinational group headquartered in The Netherlands, operates 3 plants located in The Netherlands, Spain, and Thailand. Most of FRAmelco sales are made of Glycerides (short and medium chain fatty acids) to maintain animal in good health and to improve animal performance and Lysolecithins to improve feed digestibility. FRAmelco’s industrial footprint, its product range, its technologies, the species addressed, and its target markets are highly complementary to Adisseo’s. It will allow the combined business to implement integrated solutions and offer even more value to customers who want to reduce antibiotic usage and enhance animal resilience.

Adisseo is one of the world’s leading experts in feed additives. The group relies on its 10 research centers and its production sites based in Europe, USA, and China to design, produce and market nutritional solutions for sustainable animal feed. With more than 2,250 employees, it serves around 3,900 customers in over 110 different countries through its global distribution network. In 2019, Adisseo achieved a turnover of over 1.44 billion Euros.

Adisseo is one of the main subsidiaries of China National BlueStar, leader in the Chinese chemical industry with nearly 21,000 employees and a turnover of 6,8 billion USD; the company is listed on the Shanghai Stock Exchange.

What we did

Capitalmind actively supported FRAmelco as exclusive advisor along the entire sell-side process: marketing materials preparation, screening and selection of the relevant strategic and financial buyers through a competitive process, management of the due diligence and negotiation of terms and conditions of the deal plus ultimate closing of the transactions.